Anne FOGLI
Maitre de Conférences - Praticien Hospitalie
FOGLI
Anne
Maitre de Conférences - Praticien Hospitalie
MCU-PH
Publications
The Long Non-Coding RNA HOXA-AS2 Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional Regulation.
Publié le 25 Avr 2022 dans International journal of molecular sciences , vol. 23
Le Boiteux E , Guichet PO, Masliantsev K, Montibus B , Vaurs-Barriere C, Gonthier-Gueret C, Chautard E, Verrelle P, Karayan-Tapon L, Fogli A , Court F , Arnaud P
Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage.
Publié le 30 Août 2021 dans Molecular oncology , vol. 15 - pp 1995-2010
Le Boiteux E , Court F , Guichet PO, Vaurs-Barrière C , Vaillant I , Chautard E, Verrelle P, Costa BM, Karayan-Tapon L, Fogli A , Arnaud P
Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter.
Publié le 04 Avr 2019
Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, van der Knaap MS, Fogli A , Boespflug-Tanguy O, Abbink TEM, Schiffmann R
Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.
Publié le 30 Oct 2019 dans Genome research , vol. 29 - pp 1605-1621
Court F , Le Boiteux E , Fogli A , Müller-Barthélémy M, Vaurs-Barrière C , Chautard E, Pereira B, Biau J, Kemeny JL, Khalil T, Karayan-Tapon L, Verrelle P, Arnaud P
The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma.
Publié le 20 Mar 2018 dans Oncotarget , vol. 9 - pp 15740-15756
Xavier-Magalhães A, Gonçalves CS, Fogli A , Lourenço T, Pojo M, Pereira B, Rocha M, Lopes MC, Crespo I, Rebelo O, Tão H, Lima J, Moreira R, Pinto AA, Jones C, Reis RM, Costello JF, Arnaud P , Sousa N, Costa BM
Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis.
Publié le 30 Nov 2017 dans Journal of neuro-oncology , vol. 135 - pp 381-390
Fogli A , Demattei MV, Corset L, Vaurs-Barrière C , Chautard E, Biau J, Kémény JL, Godfraind C, Pereira B, Khalil T, Grandin N , Arnaud P , Charbonneau M , Verrelle P
Imprinting control regions (ICRs) are marked by mono-allelic bivalent chromatin when transcriptionally inactive.
Publié le 29 Jan 2016 dans Nucleic acids research , vol. 44 - pp 621-35
Maupetit-Méhouas S , Montibus B , Nury D , Tayama C, Wassef M, Kota SK, Fogli A , Cerqueira Campos F , Hata K, Feil R, Margueron R, Nakabayashi K, Court F , Arnaud P
The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients’ survival.
Publié le 01 Mar 2016 dans Carcinogenesis , vol. 37 - pp 169-176
Fogli A , Chautard E, Vaurs-Barrière C , Pereira B, Müller-Barthélémy M, Court F , Biau J, Pinto AA, Kémény JL, Khalil T, Karayan-Tapon L, Verrelle P, Costa BM, Arnaud P
Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet – the RESOLVE trial.
Publié le 11 Juil 2014 dans Lipids in health and disease , vol. 13 - pp 112
Dutheil F, Walther G, Chapier R, Mnatzaganian G, Lesourd B, Naughton G, Verney J, Fogli A , Sapin V , Duclos M, Vinet A, Obert P, Courteix D, Lac G
A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease.
Publié le 01 Jan 2013 dans PloS one , vol. 8 - pp e53958
de Almeida RA, Fogli A , Gaillard M, Scheper GC, Boesflug-Tanguy O, Pavitt GD
Comparison of three methods of diagnosis of plasma unmeasured anions in critically ill patients.
Publié le 30 Oct 2013 dans Minerva anestesiologica , vol. 79 - pp 1164-72
Lautrette A, Fejjal M, Aithssain A, Phan TN, Caillot N, Fogli A , Souweine B
CSF N-glycan profiles to investigate biomarkers in brain developmental disorders: application to leukodystrophies related to eIF2B mutations.
Publié le 01 Jan 2012 dans PloS one , vol. 7 - pp e42688
Fogli A , Merle C, Roussel V, Schiffmann R, Ughetto S, Theisen M, Boespflug-Tanguy O
Developmental splicing deregulation in leukodystrophies related to EIF2B mutations.
Publié le 01 Jan 2012 dans PloS one , vol. 7 - pp e38264
Huyghe A, Horzinski L, Hénaut A, Gaillard M, Bertini E, Schiffmann R, Rodriguez D, Dantal Y, Boespflug-Tanguy O, Fogli A
[Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases].
Publié le 30 Nov 2011 dans Revue neurologique , vol. 167 - pp 802-11
Carra-Dalliere C, Horzinski L, Ayrignac X, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Sedel F, Guennoc AM, Sartori E, Laplaud D, Antoine JC, Fogli A , Boespflug-Tanguy O, Labauge P
Peptidomics analysis of lymphoblastoid cell lines.
Publié le 01 Jan 2010 dans Methods in molecular biology (Clifton, N.J.) , vol. 615 - pp 247-57
Fogli A , Bulet P
[Coupling proteinemia and serum protein electrophoresis: evaluation of the capillary technique (Capillarys 2, Sebia), experience from Clermont-Ferrand].
Publié le 01 Nov 2010 dans Annales de biologie clinique , vol. 68 - pp 657-67
Evaluation of the endoplasmic reticulum-stress response in eIF2B-mutated lymphocytes and lymphoblasts from CACH/VWM patients.
Publié le 19 Oct 2010 dans BMC neurology , vol. 10 - pp 94
Horzinski L, Kantor L, Huyghe A, Schiffmann R, Elroy-Stein O, Boespflug-Tanguy O, Fogli A
Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
Publié le 30 Août 2009 dans Brain : a journal of neurology , vol. 132 - pp 2161-9
Labauge P, Horzinski L, Ayrignac X, Blanc P , Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Sèze J, Fogli A , Boespflug-Tanguy O
Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.
Publié le 15 Déc 2009 dans PloS one , vol. 4 - pp e8318
Horzinski L, Huyghe A, Cardoso MC, Gonthier C , Ouchchane L, Schiffmann R, Blanc P , Boespflug-Tanguy O, Fogli A
Genes involved in leukodystrophies: a glance at glial functions.
Publié le 30 Mai 2008 dans Current neurology and neuroscience reports , vol. 8 - pp 217-29
Boespflug-Tanguy O, Labauge P, Fogli A , Vaurs-Barriere C
Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.
Publié le 03 Juin 2008 dans Neurology , vol. 70 - pp 2226-32
Vanderver A, Hathout Y, Maletkovic J, Gordon ES, Mintz M, Timmons M, Hoffman EP, Horzinski L, Niel F, Fogli A , Boespflug-Tanguy O, Schiffmann R
No evidence for association between the EIF2B5 gene and multiple sclerosis in French families.
Publié le 30 Mai 2008 dans Multiple sclerosis (Houndmills, Basingstoke, England) , vol. 14 - pp 573
Fogli A , Barbier C, Cournu-Rebeix I, Babron MC, Clerget-Darpoux F, Fontaine B, Boespflug-Tanguy O
Exon deletion in the non-catalytic domain of eIF2Bepsilon due to a splice site mutation leads to infantile forms of CACH/VWM with severe decrease of eIF2B GEF activity.
Publié le 30 Mai 2008 dans Annals of human genetics , vol. 72 - pp 410-5
Horzinski L, Gonthier C , Rodriguez D, Scherer C, Boespflug-Tanguy O, Fogli A
[Monoclonal IgM interference with immunoturbidimetric determination of ferritin and transferrin].
Publié le 01 Nov 2007 dans Annales de biologie clinique , vol. 65 - pp 659-62
[CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
Publié le 30 Sep 2007 dans Revue neurologique , vol. 163 - pp 793-9
Labauge P, Fogli A , Niel F, Rodriguez D, Boespflug-Tanguy O
Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families.
Publié le 24 Juil 2007 dans Neurology , vol. 69 - pp 400-2
Passemard S, Gelot A, Fogli A , N'Guyen S, Barnerias C, Niel F, Doummar D, Arbues AS, Mignot C, de Villemeur TB, Ponsot G, Boespflug-Tanguy O, Rodriguez D
The large spectrum of eIF2B-related diseases.
Publié le 02 Mar 2006 dans Biochemical Society transactions , vol. 34 - pp 22-9
Fogli A , Boespflug-Tanguy O
Peptidomics and proteomics studies of transformed lymphocytes from patients mutated for the eukaryotic initiation factor 2B.
Publié le 07 Août 2006 dans Journal of chromatography. B, Analytical technologies in the biomedical and life sciences , vol. 840 - pp 20-8
Fogli A , Malinverni C, Thadikkaran L, Combes P, Perret F, Crettaz D, Tissot JD, Boespflug-Tanguy O, Stöcklin R, Bulet P
Autosomal dominant leukodystrophy and childhood ataxia with central nervous system hypomyelination syndrome.
Publié le 30 Oct 2006 dans Annals of neurology , vol. 60 - pp 485; author reply 485-6
Labauge P, Gelot A, Fogli A , Boespflug-Tanguy O, Rodriguez D
Dominant form of vanishing white matter-like leukoencephalopathy.
Publié le 30 Oct 2005 dans Annals of neurology , vol. 58 - pp 634-9
Labauge P, Fogli A , Castelnovo G, Le Bayon A, Horzinski L, Nicoli F, Cozzone P, Pagès M, Briere C, Marty-Double C, Delhaume O, Gelot A, Boespflug-Tanguy O, Rodriguez D
Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
Publié le 30 Juil 2004 dans European journal of human genetics : EJHG , vol. 12 - pp 561-6
Fogli A , Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, Kimball SR, Boespflug-Tanguy O
The effect of genotype on the natural history of eIF2B-related leukodystrophies.
Publié le 11 Mai 2004 dans Neurology , vol. 62 - pp 1509-17
Fogli A , Schiffmann R, Bertini E, Ughetto S, Combes P, Eymard-Pierre E, Kaneski CR, Pineda M, Troncoso M, Uziel G, Surtees R, Pugin D, Chaunu MP, Rodriguez D, Boespflug-Tanguy O
Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure.
Publié le 26 Oct 2004 dans BMC women's health , vol. 4 - pp 8
Fogli A , Gauthier-Barichard F, Schiffmann R, Vanderhoof VH, Bakalov VK, Nelson LM, Boespflug-Tanguy O
Ovarian failure related to eukaryotic initiation factor 2B mutations.
Publié le 30 Juin 2003 dans American journal of human genetics , vol. 72 - pp 1544-50
Fogli A , Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R, Boespflug-Tanguy O
[eIF2B and Cree Indian leukodystrophies].
Publié le 30 Mar 2003 dans Medecine sciences : M/S , vol. 19 - pp 283-4
Fogli A , Rodriguez D, Eymard-Pierre E, Boespflug-Tanguy O
Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus.
Publié le 30 Oct 2002 dans Annals of neurology , vol. 52 - pp 506-10
Fogli A , Wong K, Eymard-Pierre E, Wenger J, Bouffard JP, Goldin E, Black DN, Boespflug-Tanguy O, Schiffmann R
A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation.
Publié le 24 Déc 2002 dans Neurology , vol. 59 - pp 1966-8
Fogli A , Dionisi-Vici C, Deodato F, Bartuli A, Boespflug-Tanguy O, Bertini E
